Liminatus Pharma, Inc. (LIMN) SEC Filings & Financial Intelligence
Liminatus Pharma, Inc. (LIMN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LIMN
CIK: 1971387
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMarc Silverman
Audit LocationWhippany, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-24 | FORM 8-K | 0001104659-26-111665 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | FORM 8-K | 0001104659-26-098335 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097304 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | FORM 8-K | 0001104659-26-090423 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | FORM 8-K | 0001104659-26-088380 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-20 | FORM 8-K | 0001104659-26-086674 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-22 | — | SCHEDULE 13G Filing | 0001104659-26-085882 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-02 | OWNERSHIP DOCUMENT | 0001104659-26-083588 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-14 | — | SCHEDULE 13D/A Filing | 0001104659-26-083585 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-13 | 2026-08-03 | DEF 14A | 0001104659-26-082905 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-06-24 | OWNERSHIP DOCUMENT | 0001104659-26-080806 | View SEC Doc Filr Page |
| 3 | 2026-07-06 | 2026-06-24 | OWNERSHIP DOCUMENT | 0001104659-26-080804 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-06 | — | SCHEDULE 13G/A Filing | 0001104659-26-080802 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-06-29 | FORM 8-K | 0001104659-26-080613 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-30 | 2026-06-29 | PRE 14A | 0001104659-26-078994 | View SEC Doc Filr Page |
| S-1 | 2026-06-24 | — | S-1 | 0001104659-26-076958 | View SEC Doc Filr Page |
| D | 2026-06-18 | — | D Filing | 0001104659-26-075732 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | FORM 8-K | 0001104659-26-070173 | View SEC Doc Filr Page |
| 424B3 | 2026-06-03 | — | 424B3 | 0001104659-26-069843 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-20 | FORM 8-K | 0001104659-26-066974 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-17 | FORM 8-K | 0001104659-26-064585 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062734 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001104659-26-037933 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-02-27 | FORM 8-K | 0001104659-26-023467 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-20 | — | SCHEDULE 13G Filing | 0001213900-26-018820 | View SEC Doc Filr Page |